Acute Toxicity Study and Elemental Analysis of Gasca N Herbal Product doi.org/10.26538/tjnpr/v3i6.6
Main Article Content
Abstract
The biological effectiveness of any herbal medicinal product depends on its safety and efficacy. In recent years the world has witnessed an increased usage of herbal medicinal products, hence their potential toxicities and adverse effects is a matter of public health importance. The study aimed to assess the acute toxicity and to determine the level of essential elements and heavy metals in Gasca N herbal product. The acute toxicity study was done according to standard procedure, where Wistar rats were administered Gasca N herbal product at a single dose of 10 mg/kg, 100 mg/kg, and 1000 mg/kg (Phase I) then 1,600 mg/kg, 2,900 mg/kg and 5,000 mg/kg (Phase II). The concentration of heavy metals (Cadmium, Arsenic, Mercury, Lead and chromium) and that of important elements like Iron, Cobalt, Zinc, Vanadium and Copper were estimated using standard procedure with Microwave Plasma-Atomic Emission Spectrometry 4200.The results of the present study demonstrated that oral administration of Gasca N herbal product up to a dose of 5,000 mg/kg did not cause any mortality or adverse effect, suggesting that the product can be considered as practically nontoxic. Heavy metal concentrations in the herbal product were found to be as follows: Pb (0.0), Hg (0.0), Cd (0.76 μg/g), Cr (2.92 μg/g), and As (0.0). Gasca N herbal product has been shown to be non-toxic. The levels of heavy metals present in Gasca N herbal product fall within the permissible limits according to WHO permissible limits, thus does not pose a significant threat to human health.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Vertuani S, Braccioli E, Buzzoni V, Manfredini S. Antioxidant capacity of Adansonia digitata fruit pulp and leaves. Acta Phytother. 2002; 86:2-7.
Nour AA, Magboul BI, Kheiri NH. Chemical composition of baobab fruit (Adansonia digitata L.). Trop Sci. 1980; 22:383-388.
Sena LP, VanderJagt DJ, Rivera C, Tin AC, Muhamadu I, Mahamadou O, Millton M, Pastuszyn A, Glew RH. Analysis of nutritional components of eight famine foods of the Republic of Niger. Plant Food Hum Nutr. 1998; 52:17- 30.
Becker B. The contribution of wild plants to human nutrition in the Ferlo (Northern Senegal). Agroforestry Syst. 1983; 1:257-267.
Odetokun SM. The nutritive value of Baobab fruit (Adansonia digitata). La Rivista Italiana delle Sostanze Grasse. 1996; 73:371-373.
Osman MA. Chemical and Nutrient Analysis of Baobab (Adansonia digitata) Fruit and Seed Protein Solubility. Plant Food Hum Nutr. 2004; 59:29-33.
Glew RH, VanderJagt DJ, Lockett C, Grivetti LE, Smith GC, Pastuszyn A, Millson M. Amino Acid, Fatty Acid and Mineral Composition of 24 Indigenous Plants of Burkina Faso. J Food Comp Analys. 1997; 10:205-217.
Ramadan A, Harraz FM, El-Mougy SA. Anti-inflammatory, analgesic and antipyretic effects of the fruit pulp of Adansonia digitata. Fitoterapia. 1993; 65:418-422.
Vimalanathan S, Hudson JB. Multiple inflammatory and antiviral activities in Adansonia digitata (Baobab) leaves, fruits and seeds. J Med Plants Res. 2008; 3:576-582.
Al-Qarawi AA, Al-Damegh MA, El-Mougy SA. Hepatoprotective Influence of Adansonia digitata Pulp. J Herbs Spices Med Plants. 2003; 10:1-6.
Anani K, Hudson JB, de Souzal C, Akpagana K, Tower GHN, Amason JT, Gbeassor M. Investigation of medicinal plants of Togo for antiviral and antimicrobial activities. Pharm Biol. 2000; 38:40-45.
Thiyagarajan V, Muthusamy P, Jayshree N, Vijaya B, Raj K. A Review on Adansonia digitata- Potential Herb. Research J Pharmacogn Phytochem. 2015; 7(1):1-4.
Hsu B, Coupar IM, Ng K. Antioxidant activity of hot water extract from the fruit of the Doum palm, Hyphaene thebaica. Food Chem. 2006; 98:317–328.
Abdel-Rahim EA, El-Beltagi H, Fayed A. Comparative studies on the influences of Juniperus phoenicea and Hyphaena thebaica as hypoglycemic factors in diabetic rats. J Adv Food Sci. 2011; 33:128–132.
Shehu B, Gidado A, Buratai L. Hypoglycaemic, hypolipidaemic and possible toxicity of the Methanolic fruit pulp extract of hyphane thebaica (L) Mart in alloxan-- induced diabetic rats. J Med Appl Biosci. 2014; 6:1-10.
Cook JA, VanderJagt DJ, Pastuszyn A, Mounkaila G, Glew RS, Millison M, Kilani S, Sghaier MB, Limem I, Bouhlel I, Boubaker J, Bhouri W, Skandrani I, Neffatti A, Ammar RB, Dijoux-Franca, MG, Ghedira K, and Chekir-Ghedira L. In vitroevaluation of antibacterial, antioxidant, cytotoxic and apoptotic activities of the tubers infusion and extracts of Cyperus rotundus. Biores Technol. 2008; 99:9004–9008.
Yang JH, Lin HC, Mau JL. Antioxidant properties of several commercial mushrooms. Food Chem. 2002; 77:229–235.
Betty Hsu, Coupar MI, Ken Ng. Antioxidant activity of hot water extract from the fruit of the Duom palm “Hyphaene thebaica”. Food Chem. 2006; 98:317–328.
Eldahshan OA, Ayoub NA, Singab AB, Al-Azizi MM. Potential superoxide anion radical scavenging activity of doum palm (Hyphaene thebaica L.) leaves extract. Rec Nat Prod. 2008; 2:83–93.
Jeong JB, Ju SY, Park JH, Lee JR, Yun KW, Kwon ST, Lim JH, Chung GY, Jeong HJ. Antioxidant activity in essential oils of Cnidium officinale makino and Ligusticum chuanxionghort and their inhibitory effects on DNA damage and apoptosis induced by ultraviolet B in mammalian cell. Cancer Epidemiol. 2009; 33:41–46.
Vassalle C, Petrozzi L, Bollo N, Andressi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Int Med. 2004; 256:308-315.
Jagadish LK, Krishnan VV, Shenbhagaraman R, Kaviyarasan V. Comparative study on the antioxidant, anticancer and antimicrobial property of Agaricus bisporus Imbach before and after boiling. Afr J Biotechnol. 2009; 8:654-661.
Martena MJ, Van Der Wielen JC, Rietjens IM, Klerx WN, De Groot HN, Konings EJ. Monitoring of mercury, arsenic and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks. U.S Nat Lib Med Contr Expo Risk. 2010; 27:190-205.
Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part1: Regulation and quality. Br J Clin Pharmacol. 2003; 55:226-233.
Zaleska A. Heavy metals: health and environmental effects of some heavy metals (concentration on RoHS Directive), Gdańsk. Chemical Faculty, Gdańsk University of Technology PG Press. 2008. 1- 27 p.
Phillips S and Balge M. Heavy metal toxicity, Texas (SA). New Fields, 2007. 1-30 p.
Lorke D. Anew approach to practical toxicity testing. Arch Toxicol. 1983; 54(4):275-287
de Benoist B ME, Egli I, Cogswell M, eds. Worldwide prevalence of anemia WHO Global Database on Anaemia Geneva, Switzerland: WHO press, 2008. 1–40. 1993-2005.
Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004; 116 Suppl 7A:11s–26s.
Vitale JJ, Broitman SA, Vavrousek-Jakuba E, Rodday PW, Gottlieb LS. The effects of iron deficiency and the quality and quantity of fat on chemically induced cancer. Adv Exp Med Biol. 1977; 91:229-242.
Prime SS, MacDonald DG, Rennie JS. The effect of iron deficiency on experimental oral carcinogenesis in the rat. Br J Cancer. 1983; 47(3):413–418.
Jagadeesan V, Rao NJ, Sesikeran B. Effect of iron deficiency on DMH-induced gastrointestinal tract tumors and occurrence of hepatocyte abnormalities in Fischer rats. Nutr Cancer. 1994; 22(3):285–91.
Attia MA, Essa SA, Nosair NA, Amin AM, El-Agamy OA. Effect of iron deficiency anemia and its treatment on cell mediated immunity. Indian J Hematol Blood Transfus. 2009; 25(2):70-77.
Tang YM, Chen XZ, Li GR, Zhou RH, Ning H, Yan H. [Effects of iron deficiency anemia on immunity and infectious disease in pregnant women]. Wei sheng yan jiu Journal of hygiene research. 2006; 35(1):79–81.
Das I, Saha K, Mukhopadhyay D, Roy S, Raychaudhuri G, Chatterjee M, Mitra PK. Impact of iron deficiency anemia on cell-mediated and humoral immunity in children: A case control study. J Nat Sci Biol Med. 2014; 5(1):158–163.
Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. The effect of iron deficiency anemia on the function of the immune system. Hematol J. 2005; 5(7):579–583.
Hung N, Shen C, Hu Y, Hu L, Yeh C, Teng C, Kuan A, Chen S, Chen T and Liu C. Risk of Cancer in Patients with Iron Deficiency Anemia: A Nationwide Population- Based Study. PLoS One. 2015; 10(3):e0119647.
Mertz W. Biological role of chromium. Federation Proceedings. 1967; 26:186–193.
WHO (World Health Organization) Aluminium. International programme on chemical safety (IPCS), environmental health criteria 194. Genf: WHO 1997. www.inchem.org/documents/ehc/ehc/ehc194.htm (la st accessed on 21 July 2017)
Anderson RA. Chromium in the prevention and control of diabetes. Diabetes and Metabolism. 2000; 26:22–27.
Tuzcu A, Bahceci M, Dursun M, Parmaksiz Y, Ertem M, Dalgic A, Turgut C, Kale E. Can long-term exposure to chromium improve insulin sensitivity in chromium mine workers? J Trace Elem Exp Med. 2004; 17:55–63.
Kim DS, Kim TW, Kang JS. Chromium picolinate supplementation improves insulin sensitivity in Goto- Kakizaki diabetic rats. J Trace Elem Med Biol. 2004; 17:243–247.
Anderson RA. Nutritional factors influencing the glucose/insulin system: Chromium. J Am Coll Nutr. 1997; 16:404–410.
Pechova A and Pavlata L. Chromium as an essential nutrient: A review. Vet Med. 2007; 52: (1):1–18
Nakai M, Watanabe H, Fujiwara C, Kakegawam H, Satoh T, Takada J, Matsushita R, Sakurai H. Mechanism of insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. Biol Pharm Bull.1995; 18:719–725.
Yanardag R, Bolkent S, Karabulut-Bulan O, Tunali S. Effects of vanadyl sulfate on kidney in experimental diabetes. Biol Trace Elem Res.2003; 95:73–85.
Koyuturk M, Tunali S, Bolkent S, Yanardag R. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats. Biol Trace Elem Res 2005; 104:233–247.
Niu Y, Liu W, Tian C, Xie M, Gao L, Chen Z, Chen X, Li L. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats. Eur J Pharmacol. 2007; 572:213–219.
Wei D, Li M, Ding W. Effect of vanadate on gene expression of the insulin signaling pathway in skeletal muscle of streptozotocininduced diabetic rats. J Biol Inorg Chem. 2007; 12:1265–1273.
Li M, Smee JJ, Ding W, Crans DC. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin- induced diabetic rats. J Inorg Biochem. 2009; 103:585–589.
Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C. Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem 2009; 103:554–558.
Poucheret P, Verma S, Grynpas MD, McNeill JH. Vanadium and diabetes. Mol Cell Biochem. 1998; 188:73– 80.
Rehder D. Structure and function of vanadium compounds in living organisms. BioMetals 1992; 5:3–12.
Thompson KH, Leichter J, McNeil JH. Studies of vanadyl sulfate as a glucose-lowering agent in STZ diabetic rats. Biochem Biophys Res Commun. 1993; 97:1549–1555.
Hanauske U, Hanauske AR, Marshall MH, Muggia VA. Biphasic effect of vanadium salts on in vitro tumor colony growth. Int J Cell Clon.1987; 5:170–178.
Basak R, Chatterjee M.. Combined supplementation of vanadium and 1-, 25-dihydroxyvitamin D3 inhibit placental glutathione S-trasferase positive foci in rat liver carcinogenesis. Life Sci. 2000; 68:217–231.
Bishayee A, Roy S, Chatterjee M. Characterization of selective induction and alteration of xenobiotic blotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis. Oncol Res.1999; 111:41–53.
Bishayee A, Chatterjee M. Inhibition of altered liver cell foci and persistent nodule growth by vanadium diethyl nitro samine-hepatocarcinogenesis in rats. Anticancer Res.1995a; 15:455–462.
Harding MM and Mokdsi G. Antitumor metallocenes: structure-activity studies and interactions with biomolecules. Curr Med Chem. 2000; 7:1289–1303.
Murthy MS, Rao LN, Kuo LY, Toney JH, Marks TJ. Anti- tumor and toxicologic properties of the organometallic anti- cancer agent vanadocene dichloride. Inorg Chem Acta 2000; 152:117–124.
Bishayee A and Chatterjee M. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethyl nitrosamine and promoted by phenobarbital. Br J Cancer.1995b; 71:1214–1220.
ATSDR (Agency of Toxic Substances and Disease Registry), Toxicological Profi le for Manganese, U.S. Department of Health and Human Services Public Health Service, 2000.
IOM, Dietary Reference Intakes: Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, Ed Institute of Medicine, National Academy Press, Washington DC, 2011.
Erikson KM and Aschner M. Neurochem. Int 2003; 43:475–480.
Fong NM, Jensen TC, Shah AS, Parekh NN, Saltiel AR, Brady MJ. J Biol Chem. 2000; 275: 35034–35039.
Paul-Ehrlich-Institut. Sicherheits bewertung von Aluminium in Therapie allergenen. www.pei.de/DE/arzneimittelsicherheit- vigilanz/archiv- sicherheitsinformationen (last accessed on 21 July 2017)
Deutsche Dermatologische Gesellschaft. Definition und Therapie der primären Hyperhidrose. S1-Leitlinie vom 15.1.2012. AWMF-Register Nr. 013/059. www.awmf.org/leitlinien (last accessed on 21 July 2017)
Klotz K, Weistenhöfer W, Neff F, Hartwig A, van Thriel C and Drexler H. The Health Effects of Aluminum Exposure. Dtsch Arztebl Int. 2017; 114(39): 653–659.